Growth of vestibular schwannomas: In situ model employing the monoclonal antibody Ki-67 and DNA flow cytometry

American Journal of Otology

Volumn 17, Issue 2, 1996, Pages 301-306

  Charabi, Samih ^a   Engel, Peter ^a   Charabi, Birgitte ^a   Jacobsen, Grete Krag ^a   Overgaard, Jens ^b   Thomsen, Jens ^a   Tos, Mirko ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

DNA flow cytometry; Ki 67; Vestibular schwannoma

Indexed keywords

DNA; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEURILEMOMA; PRIORITY JOURNAL; TUMOR GROWTH;

ADULT; AGED; ANTIBODIES, MONOCLONAL; CELL MOVEMENT; DIPLOIDY; DNA; EAR NEOPLASMS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEURILEMMOMA; PROSPECTIVE STUDIES; VESTIBULE;

EID: 0029899018     PISSN: 01929763     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Rosenblorn ML, Berens ME, Rutka JT. Recent perspectives in brain tumor biology and treatment. Clin Neurosurg 1989;35:314-35.
2. Tannok IF. Tumor growth and cell kinetics. In: Tannok IF, Hill RP, eds. The basic science of oncology. New York: Pergamon Press 1987;140-59.
3. Baserga R. The cell cycle. N Engl J Med 1981;304:453-9.
4. Hoshino T. A commentary on the biology and growth kinetics of low-grade and high-grade gliomas. J Neurosurg 1984;61:895-900.
5. Hoshino T, Rodrigues LA, Cho KG, et al. Prognostic implications of the proliferative potential of low-grade astrocytomas. J Neurosurg 1988;69:839-42.
6. Tsanaclis AM, Robert F, Michaud J, et al. The cycling pool of cells within human brain tumors: in situ cytokinetics using the monoclonal antibody Ki-67. Can J Neural Sci 1991;18:12-17.
7. Gerdes J, Lemke H, Baish H, et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-15.
8. Gerdes J. An immunohistological method for estimating cell growth fractions in rapid histopathological diagnosis during surgery. IntJ Cancer 1985;35:.169-71.
9. Van Dierendonck JH, Keijzer R, Van de Velde CJH, et al. Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells. Cancer Res 1989;49:2999-3006.
10. Verhoeven D, Bourgeois N, Derde MF, et al. Comparison of cell growth in different parts of breast cancers. Histopathology 1990:17:505-9.
11. Nishizaki T, Orita T, Funtani Y, et al. Flow-cytometric DNA analysis and imrnunohistochemical measurement of Ki-67 and BUdR labeling indices in human brain tumors. J Neurosurg 1989:70:379-84.
12. Lesser JHT, Janzer CR, Kleihues P, Fisch U. Clinical growth rate of acoustic schwarmomas, correlation with the growth fraction as defined by the monoclonal antibody Ki-67. Skull Base Surg 1991;1:11-15.
13. Wiet RJ, Ruby SG, Bauer GP. Proliferating cell nuclear antigen in the determination of growth rates in acoustic neuromas. Am J Otol 1994;3:294-8.
14. Welkoborsky HJ, Haibt G, Mann WJ, et al. Comparison of cytomorphometnc characteristics to histology and proliferation markers in acoustic neuromas. Ann Otol Rhinol Laryngol 1994;103:49-53.
15. Szeremeta W, Monsell EM, Rock PJ, Caccamo VD. Proliferation indices of vestibular schwannomas by Ki-67 and proliferating cell nuclear antigen (PCNA). Am J Otol (in press).
16. Charabi S, Engel P, Jacobsen GK, et al. Growth rate of acoustic neuroma expressed by Ki-67 nuclear antigen versus symptom duration. Ann Otol Laryngol 1993;102:805-9.
17. Bundgaard T, Sørensen FB, Gaihede M, et al. Stereologic, histopathologie, flow cytometric, and clinical parameters in the prognostic evaluation of 74 patients with intraoral squamous cell carcinomas. Cancer 1992;70:1-13.
18. Vindeløv LL, Christensen IJ. A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis. Cytometry 1990;11:753-70.
19. Nielsen K, Overgaard J, Bentzen SM, et al. Histological grade, DNA ploidy and mean nuclear volume as prognostic factor in prostatic cancer. APMIS 1993;101:614-20.
20. Nedzelski JM, Schessel DA, Pfleiderer A, et al. Conservative management of acoustic neuromas. Otolaryngol Clin North Am 1992-3:691-705.
21. Thomsen J, Tos M. Acoustic neuromas: diagnostic delay, growth rate and possible non-surgical treatment. Acta Otolaryngol (Stockh) 1988;452:26-33.
22. Thomsen J, Tos M. Acoustic neuroma: clinical aspects, audiovestibular assessment, diagnostic delay, and growth rate. Am J Otol 1990;1:12-19.
23. Charabi S, Thomsen J, Mantoni M, et al. Acoustic neuroma/vestibular schwarmoma, growth, surgical and non surgical consequences of the wait and see policy. Otolaryngol Head Neck Surg 1995;113:5-140.
24. Lee JK, Kim TS, Chiocca EA, et al. Growth of human schwannomas in the subrenal capsule of the nude mouse. Neurosurgery 1990;4:598-605.
25. Charabi S, Rygaard J, Klinken L, Tos M, Thomsen J. Subcutaneous growth of human acoustic schwannomas in athymic nude mice. Acta Otolaryngol (Stockh) 1994;114:399-405.
26. Rasmussen N, Tribukait B,. Thomson J, Holm LE, Tos M. Implications of DNA characterization of human acoustic neuromas. Acta Otolaryngol (Stockh) 1984;(suppl 406):278-81.
27. Wennerberg J, Mercke U. Growth potential of acoustic neuromas. Am J Otol 1989;10:293-6.